Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Sane

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Clinical Endocrinology|December 31, 2009
Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up studyCamilla Schalin-Jäntti, Leena Valanne, Mikko Tenhunen, et al.
Clinical Chemistry|January 28, 2006
Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controlsHelene Markkanen, Tuula Pekkarinen, Matti J Välimäki, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2014
CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinomaEeva Korpi-Hyövälti, Treena Cranston, Eeva Ryhänen, et al.
Clinical Endocrinology|May 21, 2009
Increased cancer incidence in acromegaly--a nationwide surveyRitva Kauppinen-Mäkelin, Timo Sane, Matti J Välimäki, et al.
Acta Ophthalmologica Scandinavica|June 13, 2002
High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathyRitva Kauppinen-Mäkelin, Anni Karma, Eeva Leinonen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 20, 2006
Quality of life in treated patients with acromegalyRitva Kauppinen-Mäkelin, Timo Sane, Harri Sintonen, et al.
Endocrine-Related Cancer|December 18, 2008
The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumorsSaila Kauhanen, Marko Seppänen, Jari Ovaska, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 11, 2009
[Treatment path of wound patient in the HUC medical care district]Mauri Lepäntalo, Terttuliisa Ahokas, Tuula Heinänen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2007
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patientsSaila Kauhanen, Marko Seppänen, Heikki Minn, et al.
The American Journal of Pathology|October 24, 2009
The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomasElina Heliövaara, Anniina Raitila, Virpi Launonen, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Clinical Endocrinology|December 31, 2009
Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up studyCamilla Schalin-Jäntti, Leena Valanne, Mikko Tenhunen, et al.
Clinical Chemistry|January 28, 2006
Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controlsHelene Markkanen, Tuula Pekkarinen, Matti J Välimäki, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2014
CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinomaEeva Korpi-Hyövälti, Treena Cranston, Eeva Ryhänen, et al.
Clinical Endocrinology|May 21, 2009
Increased cancer incidence in acromegaly--a nationwide surveyRitva Kauppinen-Mäkelin, Timo Sane, Matti J Välimäki, et al.
Acta Ophthalmologica Scandinavica|June 13, 2002
High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathyRitva Kauppinen-Mäkelin, Anni Karma, Eeva Leinonen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 20, 2006
Quality of life in treated patients with acromegalyRitva Kauppinen-Mäkelin, Timo Sane, Harri Sintonen, et al.
Endocrine-Related Cancer|December 18, 2008
The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumorsSaila Kauhanen, Marko Seppänen, Jari Ovaska, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 11, 2009
[Treatment path of wound patient in the HUC medical care district]Mauri Lepäntalo, Terttuliisa Ahokas, Tuula Heinänen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2007
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patientsSaila Kauhanen, Marko Seppänen, Heikki Minn, et al.
The American Journal of Pathology|October 24, 2009
The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomasElina Heliövaara, Anniina Raitila, Virpi Launonen, et al.
Pageof 5